Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Total Equity Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Total Equity
$1.2B
CAGR 3-Years
12%
CAGR 5-Years
151%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Total Equity
-CA$6.6m
CAGR 3-Years
-11%
CAGR 5-Years
-24%
CAGR 10-Years
-37%
Replicel Life Sciences Inc
XTSX:RP
Total Equity
-CA$6.6m
CAGR 3-Years
-12%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Total Equity
CA$729.1k
CAGR 3-Years
-9%
CAGR 5-Years
57%
CAGR 10-Years
N/A

See Also

What is Abcellera Biologics Inc's Total Equity?
Total Equity
1.2B USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Total Equity amounts to 1.2B USD.

What is Abcellera Biologics Inc's Total Equity growth rate?
Total Equity CAGR 5Y
151%

Over the last year, the Total Equity growth was -7%. The average annual Total Equity growth rates for Abcellera Biologics Inc have been 12% over the past three years , 151% over the past five years .

Back to Top